CME Group Inc. (NASDAQ:CME) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, October 25th.
A number of other equities analysts also recently weighed in on the company. Barclays PLC initiated coverage on CME Group in a research report on Friday, September 8th. They set an “overweight” rating and a $139.00 price target for the company. UBS AG reaffirmed a “buy” rating and set a $135.00 price target (up previously from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Deutsche Bank AG reduced their price target on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research report on Tuesday, July 4th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, Citigroup Inc. upped their price target on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $138.89.
Shares of CME Group (NASDAQ CME) traded down $0.16 on Wednesday, hitting $137.88. The company had a trading volume of 750,100 shares, compared to its average volume of 1,365,295. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a 1-year low of $111.19 and a 1-year high of $141.07. The firm has a market cap of $46,757.18, a price-to-earnings ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.71.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The business had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. During the same period in the previous year, the firm earned $1.05 EPS. CME Group’s quarterly revenue was up 5.8% compared to the same quarter last year. research analysts anticipate that CME Group will post 4.8 EPS for the current fiscal year.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total value of $342,075.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 714 shares of the stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $129.00, for a total value of $92,106.00. Following the completion of the sale, the insider now owns 28,844 shares in the company, valued at approximately $3,720,876. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,339 shares of company stock worth $1,548,086. 0.57% of the stock is owned by company insiders.
A number of hedge funds have recently bought and sold shares of CME. Fiduciary Trust Co. bought a new position in CME Group during the 2nd quarter worth $105,000. Quadrant Capital Group LLC increased its position in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares during the period. Parallel Advisors LLC increased its position in CME Group by 4.1% during the 1st quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. San Francisco Sentry Investment Group CA bought a new position in CME Group during the 2nd quarter worth $129,000. Finally, Whittier Trust Co. increased its position in CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares during the period. Hedge funds and other institutional investors own 82.63% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with our FREE daily email newsletter.